LIQUIDIA CORPORATION

LQDA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $158.3M $14.0M $17.5M $15.9M $12.9M $739.6K $8.1M
Cost of Revenue $5.9M $2.9M $2.9M $3.0M $237.7K
Gross Profit $8.1M $14.6M $13.1M $9.8M $501.9K
Gross Margin 58.0% 83.5% 82.1% 76.5% 67.9%
Operating Expenses
Research & Development $39.3M $47.8M $43.2M $19.4M $20.5M $32.2M $40.5M
SG&A Expense $157.2M $81.6M $44.7M $32.4M $23.1M $27.4M $13.6M
Operating Income $-51.4M $-121.3M $-73.4M $-38.8M $-33.8M $-59.1M $-46.8M
Operating Margin -32.5% -866.6% -419.6% -243.3% -263.0% -7,989.0% -580.1%
Interest Expense $6.3M $2.3M $762.0K $858.0K $1.4M
Pretax Income
Income Tax Expense $0 $0 $0 $0 $0 $0 $0
Net Income $-68.9M $-128.3M $-78.5M $-41.0M $-34.6M $-59.8M $-47.6M
Net Margin -43.5% -916.6% -448.9% -257.4% -269.0% -8,080.1% -589.5%
EPS (Basic) $-0.80 $-1.63 $-1.21 $-0.67 $-0.70 $-1.76 $-2.57
EPS (Diluted) $-0.80 $-1.63 $-1.21 $-0.67 $-0.70 $-1.76 $-2.57
Shares Outstanding (Basic) 88.1M 86.1M 78.7M 65.0M 61.0M 49.7M 33.9M
Shares Outstanding (Diluted) 88.1M 86.1M 78.7M 65.0M 61.0M 49.7M 33.9M 18.5M
Dividends Per Share